Indian Journal of Nephrology Home 

ORIGINAL ARTICLE
[View FULLTEXT] [Download PDF]
Year : 2015  |  Volume : 25  |  Issue : 1  |  Page : 12--15

Study of hypothalamic pituitary adrenal axis in patients of membranous nephropathy receiving modified Ponticelli regimen

R Ramachandran1, A Jairam1, A Bhansali2, V Jha1, KL Gupta1, V Sakhuja1, HS Kohli1 
1 Department of Nephrology, PGIMER, Chandigarh, India
2 Department of Endocrinology, PGIMER, Chandigarh, India

Correspondence Address:
H S Kohli
Department of Nephrology, PGIMER, Chandigarh
India

Pulse methyl prednisolone followed by oral prednisolone and abrupt switch to chlorambucil/cyclophosphamide (Ponticelli/modified Ponticelli regimen) is used in patients with idiopathic membranous nephropathy. This therapy where steroids are stopped abruptly is unphysiologic and expected to have hypothalamic pituitary adrenal (HPA) axis suppression; however, this has not been evaluated. A total of 13 consecutive adult patients with idiopathic membranous nephropathy who had completed modified Ponticelli regimen were studied. The regimen included administration of pulse methylprednisolone 1 g for 3 days followed by oral prednisolone 0.5 mg/kg/day for 27 days followed by oral cyclophosphamide at a dose of 2 mg/kg/day for the next month. This was repeated for three courses. Patients who had received corticosteroids prior to therapy were excluded. The HPA axis was evaluated after 1 month of completing the last course of steroid therapy. The evaluation was done using a low-dose adrenocorticotropic hormone stimulation test. A single intravenous bolus dose of synacthen (1 μg) was given at 9.00 am and the serum cortisol levels were estimated by radioimmunoassay at 0, 30, and 60 min. A peak cortisol level of 550 nmol/L or higher was considered as normal. Mean baseline cortisol levels was 662.3 ± 294.6 nmol/L and peak cortisol level was 767 ± 304.4 nmol/L. A total of 6 patients (46.2%) had low basal cortisol levels, only 3 (23%) had both basal and peak cortisol levels < 550 nmol/L suggestive of HPA axis suppression. To conclude, 23% of patients had suppression of HPA axis after modified Ponticelli regimen.

How to cite this article:
Ramachandran R, Jairam A, Bhansali A, Jha V, Gupta K L, Sakhuja V, Kohli H S. Study of hypothalamic pituitary adrenal axis in patients of membranous nephropathy receiving modified Ponticelli regimen.Indian J Nephrol 2015;25:12-15

How to cite this URL:
Ramachandran R, Jairam A, Bhansali A, Jha V, Gupta K L, Sakhuja V, Kohli H S. Study of hypothalamic pituitary adrenal axis in patients of membranous nephropathy receiving modified Ponticelli regimen. Indian J Nephrol [serial online] 2015 [cited 2023 Feb 1 ];25:12-15
Available from: https://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2015;volume=25;issue=1;spage=12;epage=15;aulast=Ramachandran;type=0